GF/B46/EDP21
Approved by the Board on: 28 April 2022
Decision on the Secretariat’s Recommendation on Funding from the 2020-2022 Allocation
The Board:
- Approves the funding recommended for each country disease component, and its constituent grants, aslisted in Table 1 of GF/B46/ER21 (“Table 1”);
- Acknowledges each country disease component’s constituent grants will be implemented by the proposedPrincipal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by theSecretariat in accordance with Global Fund policies;
- Affirms the funding approved under this decision (a) is subject to the availability of funding, and (b) shallbe committed in annual tranches; and
- Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for eachcountry disease component among its constituent grants, provided that the Technical Review Panel (the“TRP”) validates any redistribution that constitutes a material change from the program and fundingrequest initially reviewed and recommended by the TRP.
Budgetary Implications
This decision does not have material budgetary implications for operating expenses